• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病患者的腹部脂肪分布与外周及肝脏胰岛素抵抗

Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus.

作者信息

Miyazaki Yoshinori, Glass Leonard, Triplitt Curtis, Wajcberg Estela, Mandarino Lawrence J, DeFronzo Ralph A

机构信息

University of Texas Health Science Center and Texas Diabetes Institute, San Antonio, Texas 78229-3900, USA.

出版信息

Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1135-43. doi: 10.1152/ajpendo.0327.2001.

DOI:10.1152/ajpendo.0327.2001
PMID:12424102
Abstract

We examined the relationship between peripheral/hepatic insulin sensitivity and abdominal superficial/deep subcutaneous fat (SSF/DSF) and intra-abdominal visceral fat (VF) in patients with type 2 diabetes mellitus (T2DM). Sixty-two T2DM patients (36 males and 26 females, age = 55 +/- 3 yr, body mass index = 30 +/- 1 kg/m2) underwent a two-step euglycemic insulin clamp (40 and 160 mU. m(-2). min(-1)) with [3-3H]glucose. SSF, DSF, and VF areas were quantitated with magnetic resonance imaging at the L(4-5) level. Basal endogenous glucose production (EGP), hepatic insulin resistance index (basal EGP x FPI), and total glucose disposal (TGD) during the first and second insulin clamp steps were similar in male and female subjects. VF (159 +/- 9 vs. 143 +/- 9 cm2) and DSF (199 +/- 14 vs. 200 +/- 15 cm(2)) were not different in male and female subjects. SSF (104 +/- 8 vs. 223 +/- 15 cm2) was greater (P < 0.0001) in female vs. male subjects despite similar body mass index (31 +/- 1 vs. 30 +/- 1 kg/m2) and total body fat mass (31 +/- 2 vs. 33 +/- 2 kg). In male T2DM, TGD during the first insulin clamp step (1st TGD) correlated inversely with VF (r = -0.45, P < 0.01), DSF (r = -0.46, P < 0.01), and SSF (r = -0.39, P < 0.05). In males, VF (r = 0.37, P < 0.05), DSF (r = 0.49, P < 0.01), and SSF (r = 0.33, P < 0.05) were correlated positively with hepatic insulin resistance. In females, the first TGD (r = -0.45, P < 0.05) and hepatic insulin resistance (r = 0.49, P < 0.05) correlated with VF but not with DSF, SSF, or total subcutaneous fat area. We conclude that visceral adiposity is associated with both peripheral and hepatic insulin resistance, independent of gender, in T2DM. In male but not female T2DM, deep subcutaneous adipose tissue also is associated with peripheral and hepatic insulin resistance.

摘要

我们研究了2型糖尿病(T2DM)患者外周/肝脏胰岛素敏感性与腹部浅表/深部皮下脂肪(SSF/DSF)及腹内内脏脂肪(VF)之间的关系。62例T2DM患者(36例男性和26例女性,年龄 = 55±3岁,体重指数 = 30±1kg/m²)接受了两步正常血糖胰岛素钳夹试验(40和160mU·m⁻²·min⁻¹),同时输注[3-³H]葡萄糖。在L(4 - 5)水平通过磁共振成像对SSF、DSF和VF面积进行定量分析。男性和女性受试者在首次和第二次胰岛素钳夹步骤期间的基础内源性葡萄糖生成(EGP)、肝脏胰岛素抵抗指数(基础EGP×空腹血糖胰岛素比)和总葡萄糖处置(TGD)相似。男性和女性受试者的VF(159±9 vs. 143±9cm²)和DSF(199±14 vs. 200±15cm²)无差异。尽管体重指数(31±1 vs. 30±1kg/m²)和总体脂肪量(31±2 vs. 33±2kg)相似,但女性受试者的SSF(104±8 vs. 223±15cm²)大于男性(P < 0.0001)。在男性T2DM患者中,首次胰岛素钳夹步骤期间的TGD(1st TGD)与VF(r = -0.45,P < 0.01)、DSF(r = -0.46,P < 0.01)和SSF(r = -0.39,P < 0.05)呈负相关。在男性中,VF(r = 0.37,P < 0.05)、DSF(r = 0.49,P < 0.01)和SSF(r = 0.33,P < 0.05)与肝脏胰岛素抵抗呈正相关。在女性中,首次TGD(r = -0.45,P < 0.05)和肝脏胰岛素抵抗(r = 0.49,P < 0.05)与VF相关,但与DSF、SSF或总皮下脂肪面积无关。我们得出结论,在T2DM中,内脏肥胖与外周和肝脏胰岛素抵抗相关,且与性别无关。在男性而非女性T2DM患者中,深部皮下脂肪组织也与外周和肝脏胰岛素抵抗相关。

相似文献

1
Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus.2型糖尿病患者的腹部脂肪分布与外周及肝脏胰岛素抵抗
Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1135-43. doi: 10.1152/ajpendo.0327.2001.
2
Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type.无论体型如何,男性2型糖尿病患者内脏脂肪的主要分布与肝脏胰岛素抵抗密切相关。
Cardiovasc Diabetol. 2009 Aug 5;8:44. doi: 10.1186/1475-2840-8-44.
3
Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.吡格列酮对2型糖尿病患者腹部脂肪分布及胰岛素敏感性的影响。
J Clin Endocrinol Metab. 2002 Jun;87(6):2784-91. doi: 10.1210/jcem.87.6.8567.
4
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.非糖尿病和2型糖尿病患者肝脏/内脏脂肪与肝脏胰岛素抵抗之间的关系。
Gastroenterology. 2007 Aug;133(2):496-506. doi: 10.1053/j.gastro.2007.04.068. Epub 2007 May 1.
5
Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients.吡格列酮治疗的II型糖尿病患者的血浆抵抗素浓度、肝脏脂肪含量以及肝脏和外周胰岛素抵抗
Int J Obes Relat Metab Disord. 2004 Jun;28(6):783-9. doi: 10.1038/sj.ijo.0802625.
6
Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.2型糖尿病患者肝脏脂肪增加、胰岛素清除受损以及肝脏和脂肪组织胰岛素抵抗。
Gastroenterology. 2008 Jul;135(1):122-30. doi: 10.1053/j.gastro.2008.03.021. Epub 2008 Mar 21.
7
Metabolic effects of visceral fat accumulation in type 2 diabetes.2型糖尿病中内脏脂肪堆积的代谢效应
J Clin Endocrinol Metab. 2002 Nov;87(11):5098-103. doi: 10.1210/jc.2002-020696.
8
Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes.非酒精性脂肪肝的代谢紊乱类似于 2 型糖尿病的典型改变。
Clin Sci (Lond). 2017 Jul 7;131(15):1905-1917. doi: 10.1042/CS20170261. Print 2017 Aug 1.
9
Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat.腹部皮下脂肪和大腿肌肉组成独立于内脏脂肪预测胰岛素敏感性。
Diabetes. 1997 Oct;46(10):1579-85. doi: 10.2337/diacare.46.10.1579.
10
Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat.热量限制通过减少内脏脂肪来逆转衰老大鼠的肝脏胰岛素抵抗。
J Clin Invest. 1998 Apr 1;101(7):1353-61. doi: 10.1172/JCI485.

引用本文的文献

1
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes.代谢功能障碍相关脂肪性肝病(MASLD):肠道微生物群、胰岛素抵抗和糖尿病之间的相互作用
Front Med (Lausanne). 2025 Aug 14;12:1618275. doi: 10.3389/fmed.2025.1618275. eCollection 2025.
2
Hepatic Glucose Uptake During Euglycemic Hyperinsulinemia Associates With Glycemia During Oral Glucose Tolerance Test.正常血糖高胰岛素血症期间的肝脏葡萄糖摄取与口服葡萄糖耐量试验期间的血糖相关。
J Endocr Soc. 2025 Apr 2;9(5):bvaf054. doi: 10.1210/jendso/bvaf054. eCollection 2025 May.
3
White adipose tissue in type 2 diabetes and the effect of antidiabetic drugs.
2型糖尿病中的白色脂肪组织及抗糖尿病药物的作用
Diabetol Metab Syndr. 2025 Apr 4;17(1):116. doi: 10.1186/s13098-025-01678-9.
4
Relationship between TyG-BMI index and glycemic index with diet quality, anthropometric indices, and blood pressure in patients with metabolic syndrome.代谢综合征患者中TyG-BMI指数和血糖指数与饮食质量、人体测量指标及血压之间的关系
Medicine (Baltimore). 2025 Jan 17;104(3):e41276. doi: 10.1097/MD.0000000000041276.
5
[Research progress in regulation of hair growth by dermal adipose tissue].[真皮脂肪组织对毛发生长调控的研究进展]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2024 May 15;38(5):626-632. doi: 10.7507/1002-1892.202402092.
6
Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective.胰岛素抵抗、非酒精性脂肪性肝病和 2 型糖尿病:临床与实验视角。
Diabetes Metab J. 2024 May;48(3):327-339. doi: 10.4093/dmj.2023.0350. Epub 2024 Feb 2.
7
Assessing the usefulness of a newly proposed metabolic score for visceral fat in predicting future diabetes: results from the NAGALA cohort study.评估新提出的代谢评分对预测未来糖尿病的内脏脂肪的有用性:来自 NAGALA 队列研究的结果。
Front Endocrinol (Lausanne). 2023 Jul 19;14:1172323. doi: 10.3389/fendo.2023.1172323. eCollection 2023.
8
Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm.人类相关临床前动物模型在从 NAFLD 向 MAFLD 范式转变中的应用。
Int J Mol Sci. 2022 Nov 25;23(23):14762. doi: 10.3390/ijms232314762.
9
The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease.联合简单人体测量肥胖参数,即体重指数(BMI)和体脂指数(ABSI),评估非酒精性脂肪性肝病风险的价值。
Lipids Health Dis. 2022 Oct 20;21(1):104. doi: 10.1186/s12944-022-01717-8.
10
Abdominal obesity phenotypes are associated with the risk of developing non-alcoholic fatty liver disease: insights from the general population.腹型肥胖表型与非酒精性脂肪性肝病发病风险相关:来自普通人群的研究结果。
BMC Gastroenterol. 2022 Jun 25;22(1):311. doi: 10.1186/s12876-022-02393-9.